Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « were »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
werden < were < west  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 214.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (2009) Susan P. Bruce [États-Unis]Recent Developments in the Treatment of Rheumatoid Arthritis
000009 (2008) Misato Hashizume [Japon] ; Masahiko Mihara [Japon]Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000010 (2011) Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000012 (2005) Norihiro Nishimoto [Japon]Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000013 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000014 (2012) Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000016 (2009) Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000017 (2011) Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000020 (2011) Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
000021 (2010) Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000022 (2011) Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000023 (2009) Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000025 (2014) Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
000029 (2011) Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000031 (2005) Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000035 (2013) T. Witte [Allemagne]Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000049 (2012) Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000050 (2011) Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru HaradaCase of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000052 (2009) Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "were" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "were" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    were
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021